Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Exploratory Study to Investigate the Treatment Effect og Glatiramer Acetate (Copaxone ®) on Girls Woth Rett Syndrome

NCT02023424 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT02023424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Exploratory Study to Investigate the Treatment Effect og Glatiramer Acetate (Copaxone ®) on Girls Woth Rett Syndrome
Lead sponsor
Sheba Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2014
Completion date
February 28, 2015
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rett syndrome